No-- I have been out of CTTC for a long time. I will get back in after I see concrete steps to attract professional management---a CEO who knows how to run a company--and not just run up his accrued income bill.
CTTC needs to communicate to shareholders a clear path to eventual profitability. But the biggest concern is who, exactly, is licensed to sell Calmare to the US market? Is CTTC competing with GM's "licensee"? Can GM legally distribute in the US?
What are the prospects for insurance reimbursement?
Will CTTC ever be able to conduct a comprehensive clinical trial to support insurance reimbursement?
How will CTTC address the judgement in favor of GEOMC?
And, lastly, will Conrad look fashionable in an orange jumpsuit?
After all these questions are answered and in SEC filings and Press Releases, I will be back in CTTC for a trade.
GLTU